Literature DB >> 2194068

Effects of high concentrations of glucose on PTH secretion in parathyroid cells.

T Sugimoto1, C Ritter, J Morrissey, C Hayes, E Slatopolsky.   

Abstract

We examined the effects of high concentrations of glucose on PTH secretion from cultured bovine parathyroid cells. Increasing medium concentration of glucose caused suppression of PTH secretion. A significant suppression of PTH secretion was found within 48 hours of incubation with as little as 15 mM glucose. The addition of choline chloride to the medium did not suppress PTH secretion, although the osmolality was the same as that of the medium containing 50 mM glucose. When cells previously exposed to 50 mM glucose were reincubated in the medium containing 5 mM glucose for another 48 hours, a complete recovery of PTH secretion was observed. In the cells exposed to 50 mM glucose, the magnitude of the response of PTH secretion to 10(-6) M isoproterenol was blunted. Acid-urea gel electrophoresis revealed that the pattern of intact PTH and fragments secreted from cells exposed to high concentration of glucose was similar to that from control cells. Removal of insulin from the medium resulted in a suppression of PTH secretion similar to changes observed with high concentrations of glucose. The suppressive effects of high concentrations of glucose and lack of insulin were additive. However, we cannot exclude from the present studies whether the suppressive effects of the lack of insulin on PTH secretion was secondary to the fact that insulin may be required for the maintenance of parathyroid cells. The present studies demonstrate that glucose directly modulates PTH secretion in primary parathyroid cell culture.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194068     DOI: 10.1038/ki.1990.144

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

Review 1.  Diseases of the parathyroid gland in chronic kidney disease.

Authors:  Hirotaka Komaba; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

2.  Characteristics of bone turnover, bone mass and bone strength in Spontaneously Diabetic Torii-Lepr fa rats.

Authors:  Shuichi Kimura; Tomohiko Sasase; Takeshi Ohta; Eimei Sato; Mutsuyoshi Matsushita
Journal:  J Bone Miner Metab       Date:  2011-10-27       Impact factor: 2.626

3.  Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.

Authors:  K Sumida; Y Ubara; J Hoshino; K Mise; N Hayami; T Suwabe; M Kawada; A Imafuku; R Hiramatsu; E Hasegawa; M Yamanouchi; N Sawa; K Takaichi
Journal:  Osteoporos Int       Date:  2015-11-02       Impact factor: 4.507

4.  Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.

Authors:  Jürgen Floege; Joseph Kim; Elizabeth Ireland; Charles Chazot; Tilman Drueke; Angel de Francisco; Florian Kronenberg; Daniele Marcelli; Jutta Passlick-Deetjen; Guntram Schernthaner; Bruno Fouqueray; David C Wheeler
Journal:  Nephrol Dial Transplant       Date:  2010-04-25       Impact factor: 5.992

5.  Hyperparathyroidism in a diabetic patient on dialysis.

Authors:  Michiko Hori; Yoshifumi Ubara; Shohei Nakanishi; Naoko Inosita; Kenmei Takaichi
Journal:  NDT Plus       Date:  2008-05-06

6.  Clinical Characteristics of Patients with Diabetic Nephropathy on Maintenance Hemodialysis: A Multicenter Cross-sectional Survey in Anhui Province, Eastern China.

Authors:  Hu Chen; De-Guang Wang; Liang Yuan; Gui-Ling Liu; Heng-Jie He; Juan Wang; Sen Zhang; Li Hao
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

Review 7.  Advanced Glycation End Products, Diabetes, and Bone Strength.

Authors:  Masahiro Yamamoto; Toshitsugu Sugimoto
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

8.  Impact of Different Levels of iPTH on All-Cause Mortality in Dialysis Patients with Secondary Hyperparathyroidism after Parathyroidectomy.

Authors:  Qiu Ping Xi; Xi Sheng Xie; Ling Zhang; Rui Zhang; Yue Fei Xiao; Cheng Gang Jin; Yan Bo Li; Lin Wang; Xiao Xuan Zhang; Shu Tong Du
Journal:  Biomed Res Int       Date:  2017-06-05       Impact factor: 3.411

9.  Effects of raloxifene on bone metabolism in hemodialysis patients with type 2 diabetes.

Authors:  Osamu Saito; Takako Saito; Shinji Asakura; Tetsu Akimoto; Makoto Inoue; Yasuhiro Ando; Shigeaki Muto; Eiji Kusano
Journal:  Int J Endocrinol Metab       Date:  2012-04-20

10.  Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary--results from a nationwide clinical audit.

Authors:  István Kiss; Zoltán Kiss; Csaba Ambrus; András Szabó; János Szegedi; József Balla; Erzsébet Ladányi; Botond Csiky; Ottó Árkossy; Marietta Török; Sándor Túri; Imre Kulcsár
Journal:  BMC Nephrol       Date:  2013-07-18       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.